Literature DB >> 24211831

Regulation of galectin-3-induced apoptosis of Jurkat cells by both O-glycans and N-glycans on CD45.

Jing Xue1, Xiqiang Gao, Chunyan Fu, Zhe Cong, Hong Jiang, Wei Wang, Ting Chen, Qiang Wei, Chuan Qin.   

Abstract

Galectin-3 has been reported to induce apoptosis of Jurkat cells through binding receptors such as CD45. CD45RABC is heavily O-glycosylated and N-glycosylated, while CD45RO is only N-glycosylated. In this study, no apoptosis induced by galectin-3 was detected in CD45RO-transfected cells, whereas apoptosis of CD45RABC-transfected cells was observed, implying that O-glycans on CD45 might play roles in galectin-3-induced apoptosis. O-Glycosylation inhibition assay further suggests the role of O-glycans on CD45 in regulation of galectin-3-induced apoptosis. We also found that deglycosylation at N327 of CD45RO resulted in increased binding to galectin-3 without affecting apoptosis, while deglycosylation at N36 or N109 of CD45RO enhanced galectin-3-induced apoptosis. These data demonstrate that galectin-3-induced apoptosis of Jurkat cells is regulated by both O-glycans and N-glycans on CD45.
© 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Binding; CD45; DMEM; Dulbecco’s modified Eagle’s medium; Galectin-3; MW; N-Glycans; O-Glycans; PBST; SDS–PAGE; molecular weight; phosphate buffered saline with Tween 20; sodium dodecyl sulfate–polyacrylamide gel electrophoresis

Mesh:

Substances:

Year:  2013        PMID: 24211831     DOI: 10.1016/j.febslet.2013.10.034

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  c-Myc plays a key role in TADs-induced apoptosis and cell cycle arrest in human hepatocellular carcinoma cells.

Authors:  Dongdong Zhang; Junpeng Qi; Rui Liu; Bingling Dai; Weina Ma; Yingzhuan Zhan; Yanmin Zhang
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  David J R Fulton; Xueyi Li; Zsuzsanna Bordan; Yusi Wang; Keyvan Mahboubi; R Daniel Rudic; Stephen Haigh; Feng Chen; Scott A Barman
Journal:  Antioxid Redox Signal       Date:  2019-03-29       Impact factor: 8.401

3.  Galectin-3 Promotes ROS, Inflammation, and Vascular Fibrosis in Pulmonary Arterial Hypertension.

Authors:  Scott A Barman; Zsuzsanna Bordan; Robert Batori; Stephen Haigh; David J R Fulton
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Effects of galectin-3 protein on UVA-induced damage in retinal pigment epithelial cells.

Authors:  Frans E C Andrade; Rebeca D Correia-Silva; Joyce L Covre; Izabella Lice; José Álvaro P Gomes; Cristiane D Gil
Journal:  Photochem Photobiol Sci       Date:  2022-08-29       Impact factor: 4.328

5.  Physical tuning of galectin-3 signaling.

Authors:  Shaheen A Farhadi; Renjie Liu; Matthew W Becker; Edward A Phelps; Gregory A Hudalla
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

Review 6.  Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.

Authors:  Kamil Wdowiak; Tomasz Francuz; Enrique Gallego-Colon; Natalia Ruiz-Agamez; Marcin Kubeczko; Iga Grochoła; Jerzy Wojnar
Journal:  Int J Mol Sci       Date:  2018-01-10       Impact factor: 5.923

7.  The N-terminal tail coordinates with carbohydrate recognition domain to mediate galectin-3 induced apoptosis in T cells.

Authors:  Huiting Xue; Lu Liu; Zihan Zhao; Zhongyu Zhang; Yuan Guan; Hairong Cheng; Yifa Zhou; Guihua Tai
Journal:  Oncotarget       Date:  2017-07-25

8.  ArtinM Mediates Murine T Cell Activation and Induces Cell Death in Jurkat Human Leukemic T Cells.

Authors:  Thiago Aparecido da Silva; Patrícia Kellen Martins Oliveira-Brito; Thiago Eleutério Gonçalves; Patrícia Edivânia Vendruscolo; Maria Cristina Roque-Barreira
Journal:  Int J Mol Sci       Date:  2017-06-30       Impact factor: 5.923

9.  O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer.

Authors:  Sofia N Santos; Mara S Junqueira; Guilherme Francisco; Manuel Vilanova; Ana Magalhães; Marcelo Dias Baruffi; Roger Chammas; Adrian L Harris; Celso A Reis; Emerson S Bernardes
Journal:  Oncotarget       Date:  2016-12-13

10.  Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.

Authors:  Maria Claudia Vladoiu; Marilyne Labrie; Myriam Létourneau; Philippe Egesborg; Donald Gagné; Étienne Billard; Andrée-Anne Grosset; Nicolas Doucet; David Chatenet; Yves St-Pierre
Journal:  Oncotarget       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.